Jürgen Frevert

1.2k total citations
24 papers, 934 citations indexed

About

Jürgen Frevert is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Jürgen Frevert has authored 24 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 6 papers in Molecular Biology. Recurrent topics in Jürgen Frevert's work include Botulinum Toxin and Related Neurological Disorders (15 papers), Neurological disorders and treatments (13 papers) and Hereditary Neurological Disorders (12 papers). Jürgen Frevert is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (15 papers), Neurological disorders and treatments (13 papers) and Hereditary Neurological Disorders (12 papers). Jürgen Frevert collaborates with scholars based in Germany, Spain and United States. Jürgen Frevert's co-authors include Helmut Kindl, Kai Wohlfarth, Hans Bigalke, Reinhard Dengler, Wolfram Köller, Rungsima Wanitphakdeedecha, Jeyoung Park, Corey S. Maas, Mee Young Park and Martina Kerscher and has published in prestigious journals such as Angewandte Chemie International Edition, FEBS Letters and European Journal of Biochemistry.

In The Last Decade

Jürgen Frevert

23 papers receiving 847 citations

Peers

Jürgen Frevert

NEURO

CMN

PHYSI

DERMA

Henrique Ballassini Abdalla Brazil

Kamatham Pushpa Tryphena India

Ryuta Murakami Japan

Jennifer P. Moody United States

Sharon O’Neill Ireland

Edwin E. Reza-Zaldívar Mexico

Jae Jin An South Korea

Rebecca Graumann Chile

Emine Şekerdağ Türkiye

Farzaneh Atashrazm Australia

Henrique Ballassini Abdalla Brazil

Jürgen Frevert

68 ×0.1

NEURO

71 ×0.2

CMN

138 ×0.8

146 ×0.8

PHYSI

34 ×0.3

DERMA

Citations per year, relative to Jürgen Frevert Jürgen Frevert (= 1×) peers Henrique Ballassini Abdalla

Countries citing papers authored by Jürgen Frevert

Since Specialization

Citations

This map shows the geographic impact of Jürgen Frevert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Frevert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Frevert more than expected).

Fields of papers citing papers by Jürgen Frevert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Frevert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Frevert. The network helps show where Jürgen Frevert may publish in the future.

Co-authorship network of co-authors of Jürgen Frevert

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Frevert. A scholar is included among the top collaborators of Jürgen Frevert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Frevert. Jürgen Frevert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dressler, Dirk, Hans Bigalke, & Jürgen Frevert. (2022). The immunology of botulinum toxin therapy: A brief summary. Toxicology. 481. 153341–153341. 6 indexed citations

Park, Jeyoung, et al.. (2022). Immunogenicity Associated with Aesthetic Botulinumtoxin A: A Survey of Asia-Pacific Physicians’ Experiences and Recommendations. Plastic & Reconstructive Surgery Global Open. 10(4). e4217–e4217. 14 indexed citations

Park, Jeyoung, et al.. (2020). Neurotoxin Impurities: A Review of Threats to Efficacy. Plastic & Reconstructive Surgery Global Open. 8(1). e2627–e2627. 27 indexed citations

Kerscher, Martina, et al.. (2019). IncobotulinumtoxinA: A Highly Purified and Precisely Manufactured Botulinum Neurotoxin Type A. PubMed. 18(1). 52–57. 28 indexed citations

Frevert, Jürgen, et al.. (2018). Comparison of botulinum neurotoxin type A formulations in Asia. Clinical Cosmetic and Investigational Dermatology. Volume 11. 327–331. 22 indexed citations

Scheps, Daniel, Manuela López de la Paz, Marcel Jurk, Fred Hofmann, & Jürgen Frevert. (2017). Design of modified botulinum neurotoxin A1 variants with a shorter persistence of paralysis and duration of action. Toxicon. 139. 101–108. 12 indexed citations

Paz, Manuela López de la, Daniel Scheps, Marcel Jurk, Fred Hofmann, & Jürgen Frevert. (2017). Rational design of botulinum neurotoxin A1 mutants with improved oxidative stability. Toxicon. 147. 54–57. 4 indexed citations

Frevert, Jürgen. (2015). Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products. Drugs in R&D. 15(1). 1–9. 111 indexed citations

Frevert, Jürgen. (2010). Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®. Drugs in R&D. 10(2). 67–73. 113 indexed citations

10.

Frevert, Jürgen. (2010). Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®. Drugs in R&D. 10(2). 67–73. 6 indexed citations

11.

Frevert, Jürgen. (2009). Xeomin is free from complexing proteins. Toxicon. 54(5). 697–701. 47 indexed citations

12.

Frevert, Jürgen. (2008). Xeomin® is free from complexing proteins. Toxicon. 51. 11–11.

13.

Lombó, Felipe, Eva Künzel, Alfredo F. Braña, et al.. (2000). Die antitumorwirksame Hybrid-Verbindung Premithramycinon H verweist indirekt auf ein tricyclisches Intermediat der Biosynthese des Aureolsäure-Antibiotikums Mithramycin. Angewandte Chemie. 112(4). 808–811. 5 indexed citations

14.

Lombó, Felipe, Eva Künzel, Alfredo F. Braña, et al.. (2000). The Novel Hybrid Antitumor Compound Premithramycinone H Provides Indirect Evidence for a Tricyclic Intermediate of the Biosynthesis of the Aureolic Acid Antibiotic Mithramycin. Angewandte Chemie International Edition. 39(4). 796–799. 22 indexed citations

15.

Wohlfarth, Kai, et al.. (1997). Botulinum A toxins: units versus units. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(3). 335–340. 88 indexed citations

16.

Wohlfarth, Kai, et al.. (1997). Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic Consequences. Experimental Neurology. 147(1). 96–102. 249 indexed citations

17.

Frevert, Jürgen, et al.. (1981). Selective uptake by glyoxysomes of in vitro translated malate synthase. FEBS Letters. 129(1). 36–38. 34 indexed citations

18.

Frevert, Jürgen, Wolfram Köller, & Helmut Kindl. (1980). Occurrence and Biosynthesis of Glyoxysomal Enzymes in Ripening Cucumber Seeds. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 361(2). 1557–1566. 33 indexed citations

19.

Frevert, Jürgen & Helmut Kindl. (1980). A Bifunctional Enzyme from Glyoxysomes. European Journal of Biochemistry. 107(1). 79–86. 28 indexed citations

20.

Köller, Wolfram, Jürgen Frevert, & Helmut Kindl. (1979). Albumins, Glyoxysomal Enzymes and Globulins in Dry Seeds ofCucumis sativus: Qualitative and Quantitative Analysis. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 360(1). 167–176. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact